J David Gladstone Institutes is located in San Francisco, CA. The organization was established in 1973. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, J David Gladstone Institutes employed 530 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. J David Gladstone Institutes is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, J David Gladstone Institutes generated $84.3m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 3.9% each year. All expenses for the organization totaled $93.5m during the year ending 12/2020. While expenses have increased by 2.0% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
TO DRIVE A NEW ERA OF DISCOVERY IN DISEASE ORIENTED SCIENCE AND TO MENTOR TOMORROW'S LEADERS IN AN INSPIRING AND DIVERSE ENVIRONMENT.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE INSTITUTE OF VIROLOGY HAS MADE SIGNIFICANT CONTRIBUTIONS TO FIGHTING HIV/AIDS, PAVING THE WAY FOR MANY MEDICATIONS CURRENTLY IN USE AND LEADING TO A GLOBAL AND GROUNDBREAKING EFFORT IN HIV PREVENTION. RESEARCHERS CONTINUE TO EXPLORE THE BIOLOGICAL BASIS FOR HIV LATENCY, WHICH REPRESENTS THE GREATEST BARRIER TO A CURE. THE INSTITUTE HAS ALSO EXPANDED ITS FOCUS TO STUDY OTHER VIRUSES AND INFECTIOUS DISEASES, AND LOOK FOR UNIQUE STRATEGIES TO TREAT MULTIPLE VIRUSES AT ONCE.
THE INSTITUTE OF CARDIOVASCULAR DISEASE LEVERAGES IMPORTANT GENETIC, DEVELOPMENTAL, CHEMICAL, BIOLOGICAL SYSTEMS, COMPUTATIONAL, AND ENGINEERING APPROACHES TO STUDY HEART DISEASE AND STEM CELL BIOLOGY.
THE INSTITUTE OF NEUROLOGICAL DISEASE MAINTAINS A STRONG FOCUS ON NEURODEGENERATIVE AND NEUROINFLAMMATORY DISEASES, INCLUDING ALZHEIMER'S DISEASE AND OTHER DEMENTIAS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS (ALS), AND MULTIPLE SCLEROSIS. THE INVESTIGATORS ARE SEARCHING FOR COMMON THREADS THAT WILL ALLOW THEM TO IDENTIFY THERAPEUTIC INTERVENTIONS THAT MIGHT BENEFIT MULTIPLE CONDITIONS. THEY ARE USING UNCONVENTIONAL APPROACHES TO IDENTIFY SUCH MULTI-FACETED SOLUTIONS, WHILE ALSO LEVERAGING CAPABILITIES IN REGENERATIVE AND PERSONALIZED MEDICINE.
THE GLADSTONE INSTITUTE OF DATA SCIENCE AND BIOTECHNOLOGY INVESTS IN TALENT TO CREATE NEW WAYS TO ANALYZE AND INTEGRATE DATASETS, INCLUDING MACHINE LEARNING APPROACHES THAT LEVERAGE THE RAPID ADVANCES IN ARTIFICIAL INTELLIGENCE. IT WILL BE THE HOME FOR DEVELOPMENT OF NEW TECHNOLOGIES THAT CAN ACCELERATE DISCOVERY IN ALL AREAS OF INVESTIGATION AT GLADSTONE. GLADSTONE - UCSF INSTITUTE OF GENOMIC IMMUNOLOGY BLENDS THE LATEST GENOMICS AND GENOME ENGINEERING TECHNOLOGIES WITH IMMUNOLOGY RESEARCH TO ENGINEER THE HUMAN IMMUNE SYSTEM FOR THERAPEUTIC BENEFIT.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Deepak Srivastava President | Officer | 40 | $1,005,808 |
Lennart Mucke Director | Officer | 40 | $559,420 |
Robert Obana COO | Officer | 40 | $538,250 |
Steven M Finkbeiner Director | Officer | 40 | $512,829 |
Warner Greene Director | Officer | 40 | $512,441 |
Alex Marson Director | Officer | 40 | $510,740 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Service By Medallion Custodial Services | 12/30/21 | $617,236 |
Schwegman Lundberg Woessner Legal Services | 12/30/21 | $462,779 |
Metropolitan Electrical Construction Inc Construction Services | 12/30/21 | $260,372 |
Moss-adams Llp Accounting Services | 12/30/21 | $216,180 |
Bach Construction Inc Construction Services | 12/30/21 | $156,144 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $4,500,000 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $4,371,876 |
Noncash contributions included in lines 1a–1f | $1,604,625 |
Total Revenue from Contributions, Gifts, Grants & Similar | $8,871,876 |
Total Program Service Revenue | $58,349,338 |
Investment income | $2,682,176 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $440,195 |
Net Gain/Loss on Asset Sales | $13,604,887 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $84,274,665 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $6,080,794 |
Compensation of current officers, directors, key employees. | $1,205,133 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $32,172,627 |
Pension plan accruals and contributions | $2,810,145 |
Other employee benefits | $5,670,875 |
Payroll taxes | $2,420,244 |
Fees for services: Management | $0 |
Fees for services: Legal | $539,276 |
Fees for services: Accounting | $206,512 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $408,243 |
Fees for services: Other | $11,021,921 |
Advertising and promotion | $0 |
Office expenses | $8,458,957 |
Information technology | $670,089 |
Royalties | $136,196 |
Occupancy | $4,764,350 |
Travel | $338,058 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $6,941,278 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $6,347,196 |
Insurance | $1,204,639 |
All other expenses | $1,914 |
Total functional expenses | $93,512,759 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $881,693 |
Savings and temporary cash investments | $4,458,950 |
Pledges and grants receivable | $20,606,291 |
Accounts receivable, net | $3,338,450 |
Loans from Officers, Directors, or Controlling Persons | $1,150,000 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $1,544,448 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $2,149,757 |
Net Land, buildings, and equipment | $90,232,212 |
Investments—publicly traded securities | $93,834,795 |
Investments—other securities | $93,018,638 |
Investments—program-related | $0 |
Intangible assets | $770,491 |
Other assets | $6,421,654 |
Total assets | $318,407,379 |
Accounts payable and accrued expenses | $7,790,891 |
Grants payable | $0 |
Deferred revenue | $10,628,662 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $160,925,000 |
Unsecured mortgages and notes payable | $7,165,529 |
Other liabilities | $11,065,037 |
Total liabilities | $197,575,119 |
Net assets without donor restrictions | $94,969,738 |
Net assets with donor restrictions | $25,862,522 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $318,407,379 |
Over the last fiscal year, we have identified 33 grants that J David Gladstone Institutes has recieved totaling $13,420,231.
Awarding Organization | Amount |
---|---|
American Heart Association Inc Dallas, TX PURPOSE: RESEARCH | $2,976,140 |
William K Bowes Jr Foundation San Francisco, CA PURPOSE: TO BE USED AT THE DISCRETION OF THE PRESIDENT DEEPAK SRIVASTAVA, GENERAL SUPPORT | $2,000,000 |
Morgenthaler Foundation New York, NY PURPOSE: UNRESTRICTED GRANT | $1,500,000 |
Additonal Ventures Foundation Palo Alto, CA PURPOSE: INNOVATION AWARD | $1,200,000 |
The Roddenberry Foundation Sherman Oaks, CA PURPOSE: RESEARCH EFFORTS RELATED TO COVID-19 | $1,000,000 |
Foundation For A Better World Inc Marietta, GA PURPOSE: PROGRAM EXPENSES | $800,000 |
Beg. Balance | $25,862,522 |
Net Contributions | $51,530,817 |
Other Expense | $18,476,864 |
Ending Balance | $58,916,475 |
Organization Name | Assets | Revenue |
---|---|---|
Translational Genomics Research Institute Phoenix, AZ | $224,233,974 | $175,687,790 |
J David Gladstone Institutes San Francisco, CA | $318,407,379 | $84,274,665 |
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Torrance, CA | $198,389,340 | $88,849,610 |
Veterans Medical Research Foundation Of Sd San Diego, CA | $7,321,086 | $16,367,755 |
Huntington Medical Research Institutes Pasadena, CA | $82,259,720 | $16,674,865 |
International Anesthesia Research Society San Francisco, CA | $39,176,119 | $7,595,072 |
California Heart Center Foundation Beverly Hills, CA | $198,494 | $2,474,527 |
House Institute Foundation Los Angeles, CA | $6,887,696 | $1,568,325 |
Fanconi Anemia Research Fund Inc Eugene, OR | $8,601,390 | $4,056,234 |
The Gpcr Institute San Marcos, CA | $1,290,580 | $0 |
Musculoskeletal-Orthopedic Research And Education Foundation Phoenix, AZ | $591,829 | $1,272,150 |
Terasaki Innovation Center Inc Glendale, CA | $6,320,184 | $1,253,217 |